Saint-Laurent_2015_J.Med.Econ_18_930

Reference

Title : Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US - Saint-Laurent_2015_J.Med.Econ_18_930
Author(s) : Saint-Laurent Thibault C , Ozer Stillman I , Chen S , Getsios D , Proskorovsky I , Hernandez L , Dixit S
Ref : J Med Econ , 18 :930 , 2015
Abstract : Saint-Laurent_2015_J.Med.Econ_18_930
ESTHER : Saint-Laurent_2015_J.Med.Econ_18_930
PubMedSearch : Saint-Laurent_2015_J.Med.Econ_18_930
PubMedID: 26086535

Related information

Citations formats

Saint-Laurent Thibault C, Ozer Stillman I, Chen S, Getsios D, Proskorovsky I, Hernandez L, Dixit S (2015)
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US
J Med Econ 18 :930

Saint-Laurent Thibault C, Ozer Stillman I, Chen S, Getsios D, Proskorovsky I, Hernandez L, Dixit S (2015)
J Med Econ 18 :930